|2005N-0345|| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product|
|FDA Comment Number :||EC664|
|Submitter :||Mrs. Angela Saldarriaga||Date & Time:||10/12/2005 06:10:10|
|Organization :||Mrs. Angela Saldarriaga|
|Category :||International Public Citizen|
| One should not forget that the morning-after pill does not only prevents ovulation but also prevents the living embryo from implanting in the uterus, and that, is abortion!.
Also, several studies show that greater access to this pill does nothing to reduce surgical abortions. Other statistics show that teenage pregnancies have soared. Research has also revealed that over the counter access the morning-after pill "coincides with surges in STD rates.
Have you considered how will you handle the numerous problems which will arise especially with regard to keeping it out of the hands of minors?
Please, do not let this drug be sold so ?easy?! You have no mechanism for enforcing a regulation that prohibits sale to under aged!